Andrew Ko, MD, FASCO
Professor of Clinical Medicine; Associate Division Chief of Oncology, Division of Hematology/Oncology, UCSF; Chief Medical Officer, UCSF Pancreas Center
Professor of Clinical Medicine; Associate Division Chief of Oncology, Division of Hematology/Oncology, UCSF; Chief Medical Officer, UCSF Pancreas Center
My primary clinical and research interests focus on gastrointestinal malignancies, with a particular emphasis on pancreatic and gastroesophageal cancers. I have been responsible for developing and leading numerous clinical trials evaluating novel therapeutic strategies for these disease indications (ranging from novel cytotoxics to molecular targeted agents to immunotherapies) supported by industry collaborators, the National Cancer Institute, and various consortia/foundations. This work has included efforts to identify individual patient/tumor characteristics that influence prognosis and response to specific therapies, including both tissue- and blood-based biomarkers.
At a national level I serve as chair of the NCI’s Pancreatic Cancer Task Force; Associate Editor for the Journal of Clinical Oncology; and a member of the National Comprehensive Cancer Network Pancreatic Cancer guidelines committee, as well as having prior leadership and service roles with the American Society of Clinical Oncology (ASCO) and the GI Committee of the Alliance for Clinical Trials in Oncology cooperative group.
Leadership and administrative responsibilities at my institution (past and present) have included serving as past (interim) Chief in our Division of Hematology/Oncology, and current Associate Chief; Chief Medical Officer of the UCSF Pancreas Center; and chair of the Cancer Center scientific Protocol Review Committee and GI cancer site committee.
Brown University, Providence, RI, Sc.B., 1991, Applied Mathematics/Biology
Johns Hopkins School of Medicine, Baltimore, MD, M.D., 1995, Medicine
Board certified, Internal Medicine, 1998
Board certified, Medical Oncology, 2002